[Histoplasmosis in immunodepressed patients: study of 18 cases seen in Uberlândia, MG]

A S Borges1, M S Ferreira, M T Silvestre

  • 1Centro de Ciências Biomédicas da Universidade Federal de Uberlândia, MG, Brasil.

Insights

Histoplasmosis diagnosis relies on isolating Histoplasma capsulatum or histopathology. This fungal infection frequently affects immunocompromised patients, particularly those with AIDS, often presenting with skin lesions.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Context:

  • Histoplasmosis is a systemic fungal infection caused by Histoplasma capsulatum.
  • Diagnosis relies on microbiological culture or histopathology of affected tissues.
  • The study focuses on disseminated histoplasmosis in a specific patient cohort.

Purpose:

  • To describe the clinical characteristics and outcomes of disseminated histoplasmosis.
  • To highlight diagnostic methods and treatment responses.
  • To emphasize the significance of this mycosis in immunocompromised populations.

Summary:

  • Diagnosis was confirmed via culture of Histoplasma capsulatum from bodily fluids or histopathology.
  • The study observed disseminated disease with frequent skin, bone marrow, and lymph node involvement.
  • Common clinical findings included hepatosplenomegaly and pancytopenia.
  • Treatment with amphotericin B or itraconazole led to good clinical improvement in most patients.

Impact:

  • This research underscores the importance of recognizing histoplasmosis in immunocompromised patients, especially those with AIDS.
  • Findings suggest a predilection for cutaneous and lymphoreticular system invasion in this patient group.
  • Effective treatment strategies involve amphotericin B or azoles, with maintenance therapy crucial for recovery.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...